cytarabine and adamantane

cytarabine has been researched along with adamantane in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	1 (50.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Eggers, HJ	1
Avramis, IA; Avramis, VI; Laug, WE; Sausville, EA	1

Other Studies

2 other study(ies) available for cytarabine and adamantane

Article	Year
[Chemotherapy of virus diseases]. MMW, Munchener medizinische Wochenschrift, 1978, Jun-02, Volume: 120, Issue:22 Topics: Adamantane; Cytarabine; Humans; Idoxuridine; Influenza, Human; Interferons; Vidarabine; Virus Diseases	1978
Determination of drug synergism between the tyrosine kinase inhibitors NSC 680410 (adaphostin) and/or STI571 (imatinib mesylate, Gleevec) with cytotoxic drugs against human leukemia cell lines. Cancer chemotherapy and pharmacology, 2003, Volume: 52, Issue:4 Topics: Adamantane; Antimetabolites, Antineoplastic; Antineoplastic Agents; Benzamides; Cell Line, Tumor; Cytarabine; Dose-Response Relationship, Drug; Drug Synergism; Enzyme Inhibitors; Enzyme-Linked Immunosorbent Assay; Humans; Hydroquinones; Imatinib Mesylate; Leukemia-Lymphoma, Adult T-Cell; Piperazines; Protein-Tyrosine Kinases; Pyrimidines; Vascular Endothelial Growth Factor A; Vidarabine Phosphate	2003

Article

Year

[Chemotherapy of virus diseases].

MMW, Munchener medizinische Wochenschrift, 1978, Jun-02, Volume: 120, Issue:22

Topics: Adamantane; Cytarabine; Humans; Idoxuridine; Influenza, Human; Interferons; Vidarabine; Virus Diseases

1978

Determination of drug synergism between the tyrosine kinase inhibitors NSC 680410 (adaphostin) and/or STI571 (imatinib mesylate, Gleevec) with cytotoxic drugs against human leukemia cell lines.

Cancer chemotherapy and pharmacology, 2003, Volume: 52, Issue:4

Topics: Adamantane; Antimetabolites, Antineoplastic; Antineoplastic Agents; Benzamides; Cell Line, Tumor; Cytarabine; Dose-Response Relationship, Drug; Drug Synergism; Enzyme Inhibitors; Enzyme-Linked Immunosorbent Assay; Humans; Hydroquinones; Imatinib Mesylate; Leukemia-Lymphoma, Adult T-Cell; Piperazines; Protein-Tyrosine Kinases; Pyrimidines; Vascular Endothelial Growth Factor A; Vidarabine Phosphate

2003